Zenas Biopharma Inc [ZBIO] stock prices are down -5.02% to $9.28 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ZBIO shares have gain 13.31% over the last week, with a monthly amount drifted -14.47%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zenas Biopharma Inc [NASDAQ: ZBIO] stock has seen the most recent analyst activity on December 16, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $30. Previously, Rodman & Renshaw started tracking the stock with Buy rating on November 05, 2024, and set its price target to $34. On October 08, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $40 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $35 on October 08, 2024. Guggenheim initiated its recommendation with a Buy and recommended $45 as its price target on October 08, 2024. Citigroup started tracking with a Buy rating for this stock on October 08, 2024, and assigned it a price target of $27.
The stock price of Zenas Biopharma Inc [ZBIO] has been fluctuating between $7.79 and $26.25 over the past year. Currently, Wall Street analysts expect the stock to reach $35 within the next 12 months. Zenas Biopharma Inc [NASDAQ: ZBIO] shares were valued at $9.28 at the most recent close of the market. An investor can expect a potential return of 277.16% based on the average ZBIO price forecast.
Analyzing the ZBIO fundamentals
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.94 points at the first support level, and at 8.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.87, and for the 2nd resistance point, it is at 10.46.
Ratios To Look Out For
It’s worth pointing out that Zenas Biopharma Inc [NASDAQ:ZBIO]’s Current Ratio is 8.95. As well, the Quick Ratio is 8.95.
Transactions by insiders
Recent insider trading involved MOULDER LEON O JR, Chief Executive Officer, that happened on Dec 04 ’24 when 45000.0 shares were purchased. Chief Executive Officer, MOULDER LEON O JR completed a deal on Dec 03 ’24 to buy 25000.0 shares. Meanwhile, Chief Executive Officer MOULDER LEON O JR bought 7500.0 shares on Nov 18 ’24.
